Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by CanadianJrson Sep 26, 2016 1:13pm
139 Views
Post# 25278580

RE:RE:NR - LICENSE AMENDMENT

RE:RE:NR - LICENSE AMENDMENT A person can only guess at future revenues as of now but this is all good for us and I believe we'll see analyst raising their earnings estimates and price targets here in the coming weeks. I can imagine if we are capable of selling all of our product over the course of the next 12 months with consistent growth and sales we may even see dividends before legalization legislation is completed. And that's all just on the medical marijuana side. On the recreational side we'll be massive as well. GLTA
Bullboard Posts